ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2560

Analysis Of Global Gene Expression Of Pulmonary Endothelial Cells From Caveolin-1 Knock-Out Mice

Sonsoles Piera-Velazquez1, Zhaodong Li1, Sankar Addya2, Peter J. Wermuth1 and Sergio A. Jimenez1, 1Jefferson Institute of Molecular Medicine, Division of Connective Tissue Diseases and Scleroderma Center,Thomas Jefferson University, Philadelphia, PA, 2Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: endothelial cells, Fibroblasts, Gene Expression, systemic sclerosis and transforming growth factor

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Caveolin-1 (Cav-1) deficiency has recently been shown to participate in the pathogenesis of tissue fibrosis in Systemic Sclerosis (SSc). Although the mechanisms involved have not been fully elucidated, it has been shown that Cav-1 deficiency can induce the phenotypic conversion of quiescent fibroblasts into activated myofibroblasts, the effector cells responsible for the fibrotic process in SSc. It has also been shown that Cav-1 deficiency mediates the phenotypic conversion of endothelial cells (EC) into myofibroblasts through endothelial-mesenchymal transition (EndoMT). Furthermore, Cav-1 deficiency causes a synergistic stimulation of TGF-β-induced EndoMT. The objective of this study was to examine the differences in global gene expression patterns of Cav-1 knock-out (KO) and wild-type murine lung EC regarding genes participating in the EndoMT process.

Methods: Pulmonary EC were isolated from wild-type (WT) and cav-1 knockout (cav-1 KO) mice employing immunomagnetic methods with sequential anti-CD31 and anti-CD102 antibody selection followed by in vitroculture and treatment with TGF-β1. To assess the differences in gene expression we performed microarray analysis of RNA isolated from cultured early passage lung EC from wild-type and cav-1 KO mice, employing the Affymetrix mouse cDNA array. Pathway analysis was performed employing Ingenuity software.

Results: A large number of differentially expressed genes were identified in lung EC from cav-1 KO mouse in comparison to EC from wild-type controls, including several unexpected extracellular matrix proteins such as decorin (58-fold higher), dermatopontin (28-fold higher), and versican (17-fold higher), as well as fibroblast growth factor 7 (30-fold higher), and some metalloproteinases, such as, matrix metalloproteinase 3 which was increased 12-fold. Of interest was also the observation that podoplanin a small glycoprotein considered to be specifically expressed in EC of lymphatic origin and which is highly increased in a variety of malignant cells was elevated 17-20 fold in samples from the cav-1 KO mouse lung EC. Numerous genes involved in the EndoMT process were also found to be upregulated in the cav-1 KO mice lung EC compared with the wild-type (WT) controls.  Cav-1 deficiency caused a synergistic stimulation of the TGF-β-induced gene expression patterns although some unique genes appeared to be induced by TGF-β treatment of the Cav-1 KO cells but not by treatment of the WT cells.

Conclusion: Cav-1 deficiency results in remarkable changes in the global gene expression patterns of murine lung EC and potentiates the stimulatory effects of TGB-β1 inducing the differential expression of numerous pro-fibrotic genes and of genes involved in EndoMT. These results provide novel information about the mechanisms responsible for the participation of Cav-1 in SSc pathogenesis and further suggest that modulation of Cav-1 expression or activity/function may be a novel therapeutic target for SSc. 

Supported by NIH grant RO1 AR055660


Disclosure:

S. Piera-Velazquez,
None;

Z. Li,
None;

S. Addya,
None;

P. J. Wermuth,
None;

S. A. Jimenez,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/analysis-of-global-gene-expression-of-pulmonary-endothelial-cells-from-caveolin-1-knock-out-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology